Form 4: Hinge Health CEO Executes Planned Stock Sale
Statement of Changes in Beneficial Ownership
CEO and Co-Founder Daniel Antonio Perez reported the sale of 150,000 shares of Class A Common Stock via a Rule 10b5-1 trading plan.
Summary
- CEO and Co-Founder Daniel Antonio Perez reported the conversion and sale of Class B Common Stock into Class A Common Stock.
- Transactions occurred on May 6 and May 7, 2026, involving a total of 150,000 shares.
- Sales were executed at weighted average prices of $55.0884 and $55.0503 per share.
- All transactions were conducted under a pre-established Rule 10b5-1 trading plan adopted on September 11, 2025.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the sales were pre-planned and represent routine portfolio management by the CEO.
Positives
- Sales were executed under a pre-planned Rule 10b5-1 trading plan, indicating the transactions were not based on non-public information.
- The CEO maintains a significant remaining stake in the company, including 9,488,845 shares of Class B Common Stock held directly.
Negatives
- Insider selling can sometimes be perceived by the market as a lack of confidence in future short-term price appreciation.
Risks
- Future sales under the Rule 10b5-1 plan may continue to impact the supply of shares in the market.
- The reporting person holds 4,721,252 performance stock units which, if vested, could increase the total share count.
Future Outlook
The filing does not provide forward-looking financial guidance, as it is a disclosure of insider transaction activity.
Industry Context
StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard corporate governance practice for executives to diversify holdings without triggering market concerns regarding material non-public information.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for executives at major tech and healthcare firms to manage equity compensation.
- The volume of shares sold represents a small fraction of the CEO's total beneficial ownership.
Related Party Transactions
- Transactions were conducted by the spouse of the reporting person.
Stakeholder Impact
- Minimal impact expected as the sales were executed through a pre-arranged plan.
Next Steps
- Continued monitoring of future Form 4 filings to track further sales under the existing 10b5-1 plan.
Key Dates
| Date | Description |
|---|---|
| 2025-09-11 | Adoption date of the Rule 10b5-1 trading plan. |
| 2026-05-06 | Date of first transaction involving conversion and sale of shares. |
| 2026-05-07 | Date of second transaction involving conversion and sale of shares. |
| 2026-05-08 | Date of filing. |
Keywords
Hinge Health, Insider Trading, Form 4, Daniel Antonio Perez, Rule 10b5-1, Stock Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.